<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Four tetraploid cell lines were derived from the Epstein-Barr virus (EBV)-carrying, nonproducer Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> line Raji after colcemide treatment </plain></SENT>
<SENT sid="1" pm="."><plain>EBV early antigen (EA) was induced by P3HR-1 virus <z:e sem="disease" ids="C0038826" disease_type="Disease or Syndrome" abbrv="">superinfection</z:e> and by iododeoxyuridine treatment </plain></SENT>
<SENT sid="2" pm="."><plain>Inducibility was reduced in <z:hpo ids='HP_0000001'>all</z:hpo> tetraploid lines compared to the near-diploid counterpart </plain></SENT>
<SENT sid="3" pm="."><plain>The average number of EBV genome equivalents per tetraploid cell was 60-70, compared to 50 in diploid cells </plain></SENT>
<SENT sid="4" pm="."><plain>This contrasts with the EBV genome amplification previously observed in somatic cell hybrids </plain></SENT>
</text></document>